The Quattro valve and active infective endocarditis of the mitral valve

Journal of Heart Valve Disease

Volumn 9, Issue 4, 2000, Pages 544-551

  Middlemost, Shirley J ^a,b   Patel, Atul ^a   Sussman, Martin ^a   Manga, Pravin ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Department of Cardiology ^*  (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; FEMALE; GRAFT INFECTION; GRAM POSITIVE COCCI; HISTOPATHOLOGY; HUMAN; MALE; MITRAL VALVE REPLACEMENT; PRIORITY JOURNAL; REOPERATION; RHEUMATIC HEART DISEASE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; ANIMALS; ANTI-BACTERIAL AGENTS; BIOPROSTHESIS; CATTLE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MITRAL VALVE; PROSTHESIS DESIGN; RISK FACTORS; TIME FACTORS;

EID: 0033861282     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hammermeister KE, Sethi GK, Henderson WG, et al. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. N Engl J Med 1993;328:1289-1296
2. Ivert TSA, Dismukes WE, Cobbs CG, et al. Prosthetic valve endocarditis. Circulation 1984;69:223-232
3. Árvay A, Lengyel M. Incidence and risk factors of prosthetic valve endocarditis. Eur J Cardiothorac Surg 1988;2:340-346
4. Middlemost SJ, Sussman M, Patel A, Manga P. The stentless bovine pericardial valve: Early clinical results. J Heart Valve Dis 1999;8:174-179
5. Liao K, Seifter E, Hoffman D, Yellin EL, Frater RWM. Bovine pericardium versus porcine aortic valve: Comparison of tissue biological properties as prosthetic valves. Artif Org 1992;16:361-365
6. Frater RWM, Liao K, Waserman F. In vitro hemoThe Quattro Valve and Active Infective dynamics and durability of stentless chordally supported quadricusp mitral bioprosthesis. Cardiovascular Science and Technology Conference (Sponsors AAMI and NHLBI of the NIH) Proceedings, 1993, p. 91. AAMI, Arlington Virginia, ISBN 1-57020-008-4
7. Frater RWM, Liao K, Seifter E. Stentless chordally supported mitral bioprosthetic valve. In: Gabbay S, Prater RWM (eds.). New Horizons and the Future of Heart Valve Bioprostheses. Silent Partners, Austin, TX, 1994:103-119
8. Lytle BW. Surgical treatment of prosthetic valve endocarditis. Semin Thorac Cardiovasc Surg 1995;7:13-19
9. Middlemost S, Wisenbaugh T, Meyerowitz C, et al. A case for early surgery in native left-sided endocarditis complicated by heart failure: Results in 203 patients. J Am Coll Cardiol 1991;18:663-667
10. Vrandecic M, Gontijo B, Fantini FA, et al. Porcine mitral stentless valve mid-term clinical results. Eur J Cardiothoracic Surg 1997;12:56-62
11. Hoffman D, Gong G, Liao K, et al. Spontaneous host endothelial growth on bioprosthesis. Influence of fixation. Circulation 1992;86(Suppl.5):1175-1179
12. Frater RWM, Seifter E, Liao K, Wasserman F. Anticalcification, pro-endothelial and anti-inflammatory effect of post-aldehyde polyol treatment of bioprosthetic material. In: Gabbay S, Wheatley DJ (eds.). Advances in Anticalcific and Antidegenerative Treatment of Heart Valve Bioprostheses. 1st edn. Silent Partners, Inc., Austin, TX, 1997
13. Cohn LH, Allred EN, Cohn LA, et al. Early and late risk of mitral valve replacement. J Thorac Cardiovasc Surg 1985;90:872-881
14. Hammond GL, Geha AS, Kopf GS, Hashim SW. Biological versus mechanical valves. J Thorac Cardiovasc Surg 1987;93:182-198
15. Turina M. Prosthetic valve endocarditis. Thorac Cardiovasc Surg 1982;30:350-353
16. Larbalestier RI, Kinchla NM, Aranki SF, et al. Acute bacterial endocarditis. Circulation 1992;86(Suppl.II):II-68-II-74
17. Kawachi Y, Tokunaga K. Clinical comparative study between mitral mechanical and bioprosthetic valves. Jpn Circ J 1990;54:1525-1534
18. Mundth ED, Hakki AH, Mayo-Smith M, et al. Prosthetic valve endocarditis: Comparison of porcine heterograft and mechanical prosthetic valves. In: Bodnar E, Yacoub M (eds.). Biologic Bioprosthetic Valves. Yorke Medical Books, London, 1986:537-549
19. Czer LSC, Matloff JM, Chaux A, DeRobertis MA, Gray RJ. Comparative clinical experience with porcine bioprosthetic and St. Jude valve replacement. Chest 1987;91:503-514
20. Sweeney MS, Reul GJ, Cooley DA, et al. Comparison of bioprosthetic and mechanical valve replacement for active endocarditis. J Thorac Cardiovasc Surg 1985;90:676-680
21. Reul GJ, Sweeney MS. Bioprosthesis versus mechanical valve replacement in patients with infective endocarditis. J Cardiac Surg 1989;4:348-351
22. Butany J, Yu W, Silver MD, David TE. Morphologic findings in explanted Hancock II porcine bioprostheses. J Heart Valve Dis 1999;8:4-15
23. Grover FL, Cohen DJ, Oprian C, et al. Determinants of the occurrence of and survival from prosthetic valve endocarditis. J Thorac Cardiovasc Surg 1994;108:207-214
24. Askenes J, Husebye T, Fjeld NB, Geiran OR. Surgical treatment of infective endocarditis. Tidsskr Nor Laegeforen 1997;118:216-219
25. Bauernschmitt R, Jakob HG, Vahl C, Lange R, Hagl S. Operation for infective endocarditis: Results after implantation of mechanical valves. Ann Thorac Surg 1998;65:359-364
26. Jubair KA, Fagih A, Ashmeg A, Belhaj M, Sawyer W. Cardiac operations during active endocarditis. J Thorac Cardiovasc Surg 1992;104:487-490
27. Wilson WR. Prosthetic valve endocarditis. Incidence, anatomic location, cause, morbidity, and mortality. In: Duma RJ (ed.). Infections of Prosthetic Heart Valves and Vascular Grafts: Prevention, Diagnosis, and Treatment. University Park Press, Baltimore, MD, 1977:4
28. Block PC, DeSanctis RW, Weinberg AN, Austin WG. Prosthetic valve endocarditis. J Thorac Cardiovasc Surg 1970;60:540-548
29. Yarborough JW, Roberts WC, Reis RL. Structural alterations in tissue cardiac valves implanted in patients and in calves. J Thorac Cardiovasc Surg 1973;65:364-375
30. Calderwood SB, Swinski LA, Karchmer AW, et al. Prosthetic valve endocarditis: Analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg 1986;92:776-783
31. David TE, Bos J, Christakis GT, et al. Heart valve operations in patients with infective endocarditis. Ann Thorac Surg 1990;49:701-705
32. Horstkotte D. Prosthetic valve endocarditis. In: Horstkotte D, Bodnar E (eds.). Infective Endocarditis. ICR Publishers, London, 1991:229-261
33. Rossiter SJ, Stinson EB, Oyer PE, et al. Prosthetic valve endocarditis. Comparison of heterograft tissue valves and mechanical valves. J Thorac Cardiovasc Surg 1978;76:795-803
34. Crosby IK, Carrell R, Reed WA. Operative management of valvular complications of bacterial endocarditis. J Thorac Cardiovasc Surg 1972;64:235-246
35. Jung JY, Saab SB, Almond CH. The case for early surgical treatment of left-sided primary infective endocarditis. A collective review. J Thorac Cardiovasc Surg 1975;70:509-518
36. Richardson JV, Karp RB, Kirklin JW, Dismukes WE. Treatment of infective endocarditis: A 10-year comparative analysis. Circulation 1978;58:589-597
37. Croft CH, Woodward W, Elliot W, et al. Analysis of surgical results versus medical therapy in active complicated native valve infective endocarditis. Am J Cardiol 1983;51:1650-1655
38. Verheul HA, van den Brink RB, van Vreeland T, et al. Effects of changes in management of active infective endocarditis on outcome in a 25-year period. Am J Cardiol 1993;72;682-687
39. Jaffee WM, Morgan DE, Pearlman AS, Otto CM. Infective endocarditis: 1983-1988: Echocardiographic findings and factors influencing morbidity and mortality. J Am Coll Cardiol 1990;15:1227-1233
40. Grandmougin D, Prat A, Fayad G, Decoene C, Pol A, Warembourg H. Acute aortic endocarditis with annular destruction: Assessment of surgical treatment with cryopreserved valvular homografts implanted in a subannular position; follow up ranging from 14 to 76 months J Heart Valve Dis1999;8:234-241
41. Reardon MJ, Vinnerkvist A, LeMaire SA. Mitral valve homograft for mitral valve replacement in acute bacterial endocarditis. J Heart Valve Dis1999;8:71-73